Preferred Label : Nateglinide;

MeSH definition : A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES.;

MeSH synonym : Senaglinide; Nate-Glinide;

MeSH hyponym : AY-4166; AY4166; A-4166; A4166;

MeSH CAS label : D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-;

MeSH Related Number : 105746-37-0 ((D-Phe)-isomer); 105816-04-4 (Nateglinide); 105816-06-6 ((cis,D-Phe)-isomer);

Wikipedia link : https://en.wikipedia.org/wiki/Nateglinide;

UNII : 41X3PWK4O2;

Details


Main resources

You can consult :

A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES.

https://www.ema.europa.eu/medicines/human/EPAR/Starlix
2011
false
United Kingdom
French
English
syndication feed
Product containing nateglinide (medicinal product)
Product containing precisely nateglinide 60 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely nateglinide 120 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely nateglinide 180 milligram/1 each conventional release oral tablet (clinical drug)
Contraindications, Procedure
hypoglycemic agents
cyclohexanes
hypoglycemic agents
hypoglycemic agents
cyclohexanes
cyclohexanes
drug evaluation, preclinical
drug labeling
diabetes mellitus, type 2
drug approval
hypoglycemic agents
cyclohexanes
drug interactions
pregnancy
breast feeding
hypoglycemic agents
treatment outcome
drug therapy, combination
drug evaluation
cyclohexanes
phenylalanine
tablets
administration, oral
hypoglycemic agents
cyclohexanes
hypoglycemic agents
cyclohexanes
adult
aged
nateglinide
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug
Nateglinide

---
https://www.ema.europa.eu/medicines/human/EPAR/Trazec
2007
United Kingdom
English
French
syndication feed
Contraindications, Procedure
drug therapy, combination
treatment outcome
drug evaluation
tablets
administration, oral
diabetes mellitus, type 2
cyclohexanes
phenylalanine
cyclohexanes
hypoglycemic agents
cyclohexanes
hypoglycemic agents
adult
aged
cyclohexanes
hypoglycemic agents
drug interactions
pregnancy
breast feeding
cyclohexanes
hypoglycemic agents
cyclohexanes
cyclohexanes
hypoglycemic agents
hypoglycemic agents
drug approval
hypoglycemic agents
drug labeling
nateglinide
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug
Nateglinide

---
http://www.has-sante.fr/portail/display.jsp?id=c_399060
2001
France
evaluation of the transparency committee
tablets
Nateglinide

---
https://www.cadth.ca/sites/default/files/pdf/108_No6_nateglinide_edrug_f.pdf
https://www.cadth.ca/sites/default/files/pdf/108_No6_nateglinide_edrug_e.pdf
2001
Canada
French
English
cyclohexanes
phenylalanine
hypoglycemic agents
canada
treatment outcome
Evidence-Based medicine
diabetes mellitus, type 2
administration, oral
clinical trials as topic
nateglinide
drug evaluation
Nateglinide

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.